Literature DB >> 24984811

Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas.

Tomihiro Wakamiya1, Satoshi O Suzuki, Hideomi Hamasaki, Hiroyuki Honda, Masahiro Mizoguchi, Koji Yoshimoto, Toru Iwaki.   

Abstract

Fatty acid synthase (FASN) and carnitine palmitoyltransferase 1C (CPT1C), a brain-specific isoform of the CPT1 family, are upregulated in certain types of cancers, including gliomas. Acetyl-CoA carboxylase (ACC) catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis, and its phosphorylated form inhibits lipid synthesis. We examined the expression and subcellular localization of these fatty acid metabolism-related molecules in human gliomas. We performed immunostaining of two glioma cell lines (U373MG and U87MG) and 41 surgical specimens of diffuse gliomas with various histological grades (21 with the isocitrate dehydrogenase 1(IDH1) R132H mutation and 20 without the mutation). In the cultured glioma cells, CPT1C and phosphorylated ACC (p-ACC) were mainly localized to the nuclei, whereas FASN localized to the cytoplasm. In the surgical specimens, most glioma tissues showed nuclear staining for CPT1C and p-ACC, and cytoplasmic staining for FASN, regardless of the genetic status of IDH1 and the histological grade. Therefore, elevated cytoplasmic expression of FASN and nuclear localization of CPT1C are common among human diffuse gliomas, which may be regulated by the differential phosphorylation status of ACC in the cellular compartment.
© 2014 Japanese Society of Neuropathology.

Entities:  

Keywords:  acetyl-CoA carboxylase; carnitine palmitoyltransferase; fatty acid synthase; glioma; isocitrate dehydrogenase 1

Mesh:

Substances:

Year:  2014        PMID: 24984811     DOI: 10.1111/neup.12132

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  14 in total

Review 1.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

2.  Development of a Method for the Determination of Acyl-CoA Compounds by Liquid Chromatography Mass Spectrometry to Probe the Metabolism of Fatty Acids.

Authors:  Xiangkun Yang; Yongjie Ma; Ning Li; Houjian Cai; Michael G Bartlett
Journal:  Anal Chem       Date:  2016-12-19       Impact factor: 6.986

3.  Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress.

Authors:  Jennifer A Groves; Austin O Maduka; Robert N O'Meally; Robert N Cole; Natasha E Zachara
Journal:  J Biol Chem       Date:  2017-02-23       Impact factor: 5.157

4.  Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma.

Authors:  Yiqiang Zhou; Guishan Jin; Ruifang Mi; Junwen Zhang; Jin Zhang; Hengzhou Xu; Sen Cheng; Yunsheng Zhang; Wenjie Song; Fusheng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-06       Impact factor: 4.553

Review 5.  The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.

Authors:  Junmin Wang; Hongjiao Xiang; Yifei Lu; Tao Wu; Guang Ji
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

6.  AMPAR interacting protein CPT1C enhances surface expression of GluA1-containing receptors.

Authors:  Esther Gratacòs-Batlle; Natalia Yefimenko; Helena Cascos-García; David Soto
Journal:  Front Cell Neurosci       Date:  2015-02-02       Impact factor: 5.505

Review 7.  Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.

Authors:  Q Qu; F Zeng; X Liu; Q J Wang; F Deng
Journal:  Cell Death Dis       Date:  2016-05-19       Impact factor: 8.469

8.  Comparison of three ¹⁸F-labeled carboxylic acids with ¹⁸F-FDG of the differentiation tumor from inflammation in model mice.

Authors:  Hongliang Wang; Ganghua Tang; Kongzhen Hu; Tingting Huang; Xiang Liang; Zhifang Wu; Sijin Li
Journal:  BMC Med Imaging       Date:  2016-01-12       Impact factor: 1.930

Review 9.  The carnitine system and cancer metabolic plasticity.

Authors:  Mariarosa Anna Beatrice Melone; Anna Valentino; Sabrina Margarucci; Umberto Galderisi; Antonio Giordano; Gianfranco Peluso
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

10.  Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.

Authors:  Gábor Petővári; Zoltán Hujber; Ildikó Krencz; Titanilla Dankó; Noémi Nagy; Fanni Tóth; Regina Raffay; Katalin Mészáros; Hajnalka Rajnai; Enikő Vetlényi; Krisztina Takács-Vellai; András Jeney; Anna Sebestyén
Journal:  Cancer Cell Int       Date:  2018-12-19       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.